A novel multifeature human papillomavirus (HPV) whole genome sequencing liquid biopsy assay detected circulating tumor HPV DNA (ctHPV DNA) with 79% sensitivity and 100% specificity up to 7.8 years ...
Mitchell is an associate professor at the University of Virginia and an NIH-funded nurse scientist. Kueter, a former health journalist and public radio reporter, works as a magazine editor at UVA ...
A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human ...
Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) are advancing the understanding of a ...
A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human ...
One pillar of the World Health Organization’s (WHO) global cervical cancer elimination strategy includes that at least 70% of women are screened for cervical cancer using a high-performance test. WHO ...
Demographic and socioeconomic disparities in early-onset squamous cell carcinoma of the cervix: A National Cancer Database analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting ...
A pilot study suggested that the Cellient Automated Cell Block System can be used to prepare cervical scrape samples as ...
Testing period blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for a smear test, researchers have said. Using a regular sanitary pad topped with a blood sample ...
A prospective, randomized control trial of concurrent paclitaxel and carboplatin along with radiotherapy versus concurrent cisplatin along with radiotherapy in carcinoma cervix patients at a tertiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results